New white paper published : A reliable method for tumor monitoring in preclinical oncology with HawkCell
We’re delighted to unveil our latest white paper : “MRI to track subcutaneously implanted lymphoma in a preclinical mouse model” – the result of a powerful collaboration between Antineo and the incredible team at HawkCell.
Why is this important? In a nutshell, here’s what we highlighted
- Greater precision: MRI offers highly accurate 3D volumetric assessment
- Ethical benefit: This non-invasive technique reduces the number of animals needed – perfectly in line with the 3R principles (Replacement, Reduction, Refinement).
- Robust, reusable data: MRI imaging enables retrospective analysis (radiomics, texture, progression), unlocking more information from each study.
This work with Hawkcell demonstrates how cutting-edge imaging technologies can lead to significant advances in preclinical cancer research.
Download the full white paper here